JAGUAR HEALTH, INC. Public Float
JAGUAR HEALTH, INC. (JAGX) had Public Float of $3.80 million as of 2025-06-30, per its 10-K filed 2026-04-07.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-04-07
- 2025-06-30: Entity Public Float $3.80M.
- 2024-06-30: Entity Public Float $28.00M.
- 2023-06-30: Entity Public Float $9.90M.
- 2022-06-30: Entity Public Float $25.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $3.80M 10-K · filed 2026-04-07 |
| 2024-06-30 | $28.00M 10-K/A · filed 2025-04-15 |
| 2023-06-30 | $9.90M 10-K/A · filed 2024-04-17 |
| 2022-06-30 | $25.00M 10-K/A · filed 2023-04-28 |
| 2021-06-30 | $215.62M 10-K · filed 2022-03-11 |
| 2020-06-30 | $14.76M 10-K · filed 2021-03-31 |
| 2019-06-30 | $8.46M 10-K · filed 2020-04-03 |
| 2018-06-30 | $12.41M 10-K · filed 2019-04-10 |
| 2017-06-30 | $6.57M 10-K · filed 2018-04-09 |
| 2016-06-30 | $11.29M 10-K · filed 2017-02-15 |
| 2015-06-30 | $10.48M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |